Showing results (2901-2910 of 3,030) with videos related to

Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|November 27, 2009
Global vision about the biological medicinal products: biosimilars (April, 2009)Leyre Zuñiga, Begoña Calvo
Current Pharmaceutical Biotechnology|July 13, 2017
Adulteration Practices of Psychoactive Illicit Drugs: An Updated ReviewRenata Solimini, Maria C Rotolo, Manuela Pellegrini, et al.
Current Pharmaceutical Biotechnology|April 19, 2018
Harvesting, Isolation and Differentiation of Rat Adipose-Derived Stem CellsPanayiotis D Megaloikonomos, Georgios N Panagopoulos, Myrto Bami, et al.
Current Pharmaceutical Biotechnology|June 21, 2018
Replacement Therapies in Metabolic DiseaseAlexander S Keller, T C Stevenson Keller Iv, Leon J DeLalio, et al.
Current Pharmaceutical Biotechnology|June 12, 2018
Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular CarcinomaRyan L Setten, Helen L Lightfoot, Nagy A Habib, et al.
Current Pharmaceutical Biotechnology|February 21, 2015
Emulsomes meet S-layer proteins: an emerging targeted drug delivery systemMehmet H Ucisik, Uwe B Sleytr, Bernhard Schuster
Current Pharmaceutical Biotechnology|February 7, 2015
Bone regeneration with biomaterials and active molecules deliveryMatteo D' Este, David Eglin, Mauro Alini, et al.
Current Pharmaceutical Biotechnology|February 7, 2015
Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activityBiswajit Mukherjee, Laboni Mondal, Samrat Chakraborty, et al.
Current Pharmaceutical Biotechnology|February 7, 2015
Mango polyphenols and its protective effects on diseases associated to oxidative stressAlberto J Núñez Sellés, Diana G Villa, Luca Rastrelli
Current Pharmaceutical Biotechnology|June 18, 2014
Platelet-rich plasma induces mixed osteogenic/osteoclastogenic phenotype in osteosarcoma SaOS-2 cells: role of TGF-betaSimona Martinotti, Laura Mazzucco, Valeria Balbo, et al.
Pageof 303